Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The global non-invasive respiratory monitoring market is poised for substantial growth, projected to increase from an estimated valuation of USD 8.4 Billion in 2023 to USD 15.0 Billion by 2033, at a ...

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

We want them to stop copying our design.” He criticized Masimo for focusing on its innovations in pulse oximetry—technology that measures blood oxygen levels—arguing that the infringement still ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple ... tech giants and health technology firms are set to redefine the scope of personal ...

We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.